共 50 条
- [1] Efficacy and Safety of the First 6-Month Subcutaneous Leuprolide Acetate for Treatment of Central Precocious Puberty HORMONE RESEARCH IN PAEDIATRICS, 2020, 93 : 171 - 172
- [3] Clinical experience with 6-month subcutaneous leuprolide acetate for central precocious puberty JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2023, 72 : 202 - 203
- [4] 6-Month Subcutaneous Leuprolide Acetate Effectively Suppresses Clinical Signs of Puberty in Children with Central Precocious Puberty JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2021, 58
- [6] 6-month Subcutaneous Leuprolide Acetate Increased Predicted Adult Height in Children with Central Precocious Puberty JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2022, 64 : 160 - 160
- [7] Phase 3 Trial of a Small-volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (10):
- [9] EFFICACY OF DEPOT LEUPROLIDE ACETATE THERAPY FOR CENTRAL PRECOCIOUS PUBERTY CLINICAL RESEARCH, 1990, 38 (03): : A860 - A860